Charts. I just hope that Starpharma shareholders sit up and notice at how the leaders of our company (the Chairman and CEO). I have today made my own enquiries with AstraZeneca directly on 1-877-240-9479 and they (Camellia) have confirmed that this trial is not yet recruiting and she also confirmed that the day recruitment starts the status on the website will be updated. 199920. Created with Sketch. “It wouldn't surprise me if Starpharma have and are talking with big pharma in a joint collaboration to further develop SPL7013 for other. 5. . I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. 62). It totally unrealistic that Merck will enter the clinic in 4-5 months. . Some have been mentioned on this thread previously. All the case studies have already been touted by SPL in various ASX announcements and the only trial that is declared finished by Starpharma and scheduled for readouts is DEP Cabazitaxel and that isn't until in Q3 CY2023 ,. Attached link highlights some of the complexities involved more broadly. 59pm 20/11/2023 ? HotCopper has news, discussion, prices and market data on MESOBLAST LIMITED. 10/10/23. Your post is very vague in its relationship somehow with spl, but the intent of the constant negative narrative is obvious. 0¢ Sentiment: Buy. . It’s incredibly important to keep us informed. DISCOVER THE BATTERY METALS. Ineffective deals and sloppy clinical trials and regulatory tactics might be able to be gloss over for years but over times it show in the bottom line. 17112. Can anybody load up the most recent Bell Potter Analysis on SPL? I am unable to source it thanks. 48. Melbourne, Australia; 16 March 2021: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that its second radiopharmaceutical candidate, DEP® HER2-lutetium, achieved potent and durable anticancer activity, with complete tumour regression, outperforming Herceptin® (trastuzumab) labelled with lutetium, in a human breast cancer model (BT474). 0¢. Latest Posts. SUBMISSION STEPS. The thread is titled so that it can be found and general enough so as to. MGU Magnum Mining and Exploration piecing together optimal logistics plan for Buena Vista iron ore projectI don’t hold, but depending on timing with other investments and Starpharma developments I may become a SPL holder again if the SP drops another 10-20%. I can't guess where or what or when, perhaps there is an informed opinion out there in HC SPL land but we have a very tight market and some. bc. Last updated 10. 26. Meanwhile SPL seems to get into more schoolyard fights and then disagreements with Authority than company I have watched. 0¢. Created with Sketch. The borders are now open Look forward to a positive outcome with new partnership agreements permeating from our team networking at ASCO. Last updated 15. Forums. SPL. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Build your trading strategy and connect with. Shouldn’t company have announced departure of key person when. ASX - Day TradingLet's face it SPL is a very small investment for most of the institutions, they work on the basis of having a portfolio of these "penny dreadfuls" and expect some to come good but most to fail. Friday 26/06/2020 looks like the slide deck is very similar if not identical to last Friday's audio presentation I will be recording audio just in case this audio presentation is differentSPL management team get bad marks for delays all the time but I don’t read anyone citing possible reasons. Join the HotCopper ASX share market forum today for free. . . Target our investor community with our suite of Hotcopper Advertising opportunities. Market . As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). SPL Price at posting: 14. 9¢. Created with Sketch. Join the HotCopper ASX. ASX - Short Term Trading. Notice to Sellers of Vapour Products – PST Rate Increase to 20% Page 3 of 3 Need more info? Online: gov. Become a member of Australia's largest investment discussion forum. Right size, can penetrate deep into tumour tissue, right architecture, hang around long enough to do the job, soluble so the. Market Cap $55. Last post JoeSalami. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Market . ASX - Day TradingIn my opinion, most rational people would have to concede/agree that Starpharma’s three SPL7013 commercialised products (Fleurstat, condoms and Viraleze) have been commercial flops so far. Created with Sketch. 2327/7/2021 CSL $292. ASX - By Stock. The upper and lower pennant lines will intersect in three months. 75802. ASX - By Stock. . Join the HotCopper ASX share market forum today for free. Application for quotation of securities - SPL. Latest Posts. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Do they actually work day in day out? Do research everyday? If so why after 20 years we are still at phase 1/2. 0. FDA, TGA, MHRA to pick fights and get knocked out and 2 blood noses. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. 0¢. . Target our investor community with our suite of Hotcopper Advertising opportunities. 57pm 13/11/2023 ? HotCopper has news, discussion, prices and market data on SUNRISE ENERGY METALS LIMITED. The AGM has come and gone What did we learn from this meeting according to our attendee's who post on HotCopper forum When it comes to. The sycophants, pompom-wavers, management apologists, cheerleaders and perennial uprampers of SPL on a Hotcopper know who they are. Commodities. While the chart is not good there is a glimmer hope maybe emerging. 5,006,219 was the total short sales as of 21/07/23 (1. Safety, tolerability and side effects appear to be superior to all the base drugs, and that should be enough to sell the licenses. I averaged down over the next year and the lowest point I bought was at 57c. ASIC said Govinda faces a maximum penalty for each charge of 10 years’ prison, or a fine of up to $765,000, or both, after he entered the guilty pleas on Monday. any other information the entity wishes to notify to ASX about the cessation?The Performance Rights issued under an employee incentive scheme lapsed during the course of the quarter ended 30June 2023 include 519,053 Rights held by KMP, Nigel Baade, and 310,760 Rights held by non-KMPs. Last edited by sarge17 : 19/09/20 SPL Price at posting: $1. 50 At this stage in the game, I would not accept anything under $5 (fact)Btw if Starpharma do receive an upfront milestone of $300 million for Dep Docetaxel, Dep Cabazitaxel and Dep Irinotecan license, I believe a special dividend will be paid out to all. 59pm 20/11/2023 ? HotCopper has news, discussion, prices and market data on PANCONTINENTAL ENERGY NL. 22%) 3,361,416 was the lowest point of total short sales for some years as of 15/06/23 (0. SPL. SPL. ASIC said Govinda faces a maximum penalty for each charge of 10 years’ prison, or a fine of up to $765,000, or both, after he entered the guilty pleas on Monday. , page-2. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . HotCopper has news,. Charts. Only 12 episodes made but so Iconic . Created with Sketch. 00%. Share Given the current status of Starpharma, I am surprised any of these made it through from 2020 but it appears 121,082 did. 15667. Market Cap $57. The results will be good but will they be good enough for SPL to be able to do the deals. Market . $-0. and even when Big pharma are challenged legally and lose in court as in Johnson and Johnson bladder slings - its 20 years after the tort, 8 yrs fighting in court to then be waiting waiting waiting for compensation not for pain and suffering in VICTORIA just inconvenience costs such as buying pads and pain killers. VivaGel BV/Fleurstat was for many years touted as being a company maker in it’s own right. ASX - Day TradingThe short position has been negligible in Starpharma since we go booted from the ASX300 and the shorts were able to cover a large portion of their position at rock bottom share prices in the re-balance. All ETFs by Morningstar Ratings Morningstar Medalist Rating Gold. You should withdraw the statement. ASX - Day Trading. Along with SPL's seemingly better ADC compared to AZ's Enhertu, perhaps Pascal Soriot is wondering if he jumped into bed with the the wrong partner in Daiichi-Sankyo. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Join the HotCopper ASX share market forum today for free. 40. ASX - By Stock. opportunities galore IMO but we are likely to miss the boat again based on past performance of JF & Co. Last updated 14. Eight (8) contributors to the HC SPL thread made price predictions (thank. As Waldemar Januszczak said when looking at the portrait of Mr & Mrs Andrews by Gainsborough "THERE IS SOMETHING GOING ON here". 73. In SPL's case there is clearly another. To make matters worse he has AZD0466 on hold through no fault of the dendrimer technology, which appears to be highly successful in dealing with the drugs toxicity. Created with Sketch. 6. Join the HotCopper ASX share market forum today for free. SPL - still awaiting human trials!Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Twelve month SPL daily chartSame old trend continues. 5¢. Starpharma is listed on the Australian stock exchange (ASX:SPL). *talks with BIG multinational Company, should've already taken place with deals completed and signed soon after the trial. ASX - By Stock. The recent announcement about Viraleze nasal. 52 (16th Feb) on the back of the hype that surrounded the launch of VIRALEZE in UK/EU/WORLD. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. Hey, "smart", I concur with your message. In March 2020 the SPL share price dropped to a low of 0. Share So I am guessing nothing came from the Merck meeting Jackie given they were promoted by name in the Shareholder Update on 3 June as a big meeting to be held on the USA holiday ASCO trip and they have been a 'partner' (and I use that term lightly with this mob) for 10 months longer than Genentech so Merck's research should be much further advanced IMO there’s money to be made trading SPL but I do not believe in holding, hoping, trusting and loving SPL at all. Target our investor community. It looks like SPL will need a BLOCKBUSTER ANNOUNCEMENT with $$$$$ attached plus a SATURN ROCKET up its clacker to take off. . The Vancouver Island Wave program is the Island’s highest level of youth soccer participating in the BC Soccer Premier League. I look forward to holding SPL at task - this will be the third time I have been involved in pushing for a shareholder class action, which I can say on the previous two occasions resulted in a more communicative and transparent company, which ultimately is what I. 0¢. bc. I've been a SPL shareholder since Nov 2015 when I bought a small parcel at 91c. Some years ago SPL failed an FDA trial for the same product when Jackie was CEO. Forums. No China virus, no Flu, no colds. Offers an alternative as reasons for delays, been at the mercy of regulators playing catch-up somewhat. I have just sent. 88. 8327/7/2021 SPL $1. June 9 (Reuters) - Starpharma Holdings Ltd (SPL) : STARPHARMA CEO TO RETIRE IN 2024 FOLLOWING SIGNIFICANT TENURE AS COMPANY'S CHIEF EXECUTIVE OFFICER. ASX - By Stock. If only SPL management would undertake Human Trials for Viraleze ? The experts are leaning towards more nasal spray use including as vaccines but our management are too busy organising their free shares. 52pm 13/10/2023 ? HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. . Join the HotCopper ASX share market. PEG-b-pHPMA-lactate: Docetaxel, microtubule inhibitor/hydrolytic linkerwaste of cash by the time spl manage to do anything with nasal spray covid will have a vaccine if there is one thing spl have deomstrated it is an inability to do anything in a timely fashion. Expanding claims in UK- hmmm it would be a gamble by SPL to choose to put up that option rather than continue as is as MHRA may have same questions TGA has got ( whatever exactly they are) that don't seem to be resolved. Hey, "smart", I concur with your message. DJPIN. 1dB. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. ASX - By Stock. Created with Sketch. ASX - Day TradingMelbourne, Australia; 6 May 2021: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that VIRALEZE™ antiviral nasal spray is now available for purchase by consumers in Europe via Starpharma’s webstore. I will be unable to listen to the AGM but look forward to listening to the audio and reading Hotcopper comments and feed back after my afternoon shift. Created with Sketch. 0¢. . . I have no problem with the way SPL accessed the market initially but percieved issues over time and this may be one. Some links within this article worth a scan too. Created with Sketch. 70. Antibotter despite you starting 23 separate Starpharma threads in 3 weeks you do not own this Hotcopper forum. Latest Posts. . Prior to the trial results being released SPL need to get on the front foot. Follow your favourite stocks, view charts, track. 129294. HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. When it goes to 62 cents, and it will as it's 1 cent away, it will be a 282-week low, or 5 years 8 months since it's been at that level, that's a lot of holders if not all on them in the red. It is, to me, incredibly frustrating that SPL releases a good report with great promise and income mentions yet the market response is LIMP with a rise of. 48. I sold out of my position in SPL at that time precisely because of this. 56. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. Created with Sketch. J K Fairley $1,272,084N J Baade. Created with Sketch. I am STILL inviting comment on SPL and their Zika proclamations, and how this is evidence of SPL’s long standing crumb throwing method. ” This, sadly, is not true. 52pm 13/10/2023 ? HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. Energy. Since then. Last updated 15. . ASX - Day Trading SUBMISSION STEPS. Comments. 8985. Join the HotCopper ASX share market forum today for free. 00% 14. Last updated 15. That won’t be a shock to. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . I find it alarming the number of column inches in the resolution explanatory notes, extolling their experiences prior to spl, when not one of them has any achievements in the advancement of spl listed. Based on SPL's announcements and on reports of the AGM, my opinion is that the tune of the song that SPL sings never changes. 19/09/23. 13. Created with Sketch. Hey, "smart", I concur with your message. also not sure why anyone should get excited about a daily decrease in the short position of 0. Still waiting for you @antibotter to explain why it appears you tried to influence newbies and less experienced investors into thinking that something big was imminent based on a comment in the SPL newsletter. 75. This extract caught my eye"The AstraZeneca programs involves $US124 million of milestones, about half of which are “relatively near”. Enquire Now & Supercharge Your Brand with HotCopper 17 Oct 2023. - 12:30 p. It is now more than ever that SPL needs to communicate with the market and keep everyone informed of any updates, because the radio silence and smoke and mirrors approach is evidently NOT WORKING. All the case studies have already been touted by SPL in various ASX announcements and the only trial that is declared finished by Starpharma and scheduled for readouts is DEP. Created with Sketch. Talk with one of our capital market experts to learn more about our innovative and. Stay informed on the day’s latest market trends and receive exclusive access to HotCopper’s trending analysis with inside stories from TMH to help you make sense of what’s happened and navigate what’s ahead. Its time SPL got down and dirty and prepare their WAR plan in anticipation of the trial being successful. A correctly formatted example follows: Title of my presentation for the conference. * All the touted pending/expected deals with the Majors come to very little with the usual statement "in discussions"Created with Sketch. Your statement below masquerading as a fact could mislead less experienced investors on this Hotcopper forum. Join the HotCopper ASX share market forum today for free. Deliver ZERO dividends, a NEGATIVE capital return and depressed share price to shareholders over a 17 year period. IPOs. 5¢. SPL have put a lot of time and energy into Docetaxel and Cabazitaxel over many years but it is Irinotecan that seems to be wining the race, probably benefiting from the accrued knowledge from the Doc and Cab trials. 57. HotCopper has over 250,000 registered members, and more than 200,000 unique visitors every month and a huge 21 million monthly page impressions. ASX - By Stock. SPL always has tantalising carrots to dangle before the eyes of investors. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . A sad state of affairs IMO. Is this a case of short memories? The best one can say is her surprise is disingenuous. SPL. And he still is Chairman or Director of SIX other companies. Created with Sketch. HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. ASX - General. Click for more information. HotCopper is Australia's largest free and independent stock market trading forum for ASX share prices & stock market discussions. 971M ! Add to my watchlist. Volume. 0000. Share New future tech coming Antibody fragment-nanoparticle therapeutic eradicates cancerPosted YesterdayA multi-institutional team of researchers found novel cancer therapeutic, combining antibody fragments with molecularly engineered nanoparticles, permanently eradicating gastric cancer in treated mice. Contacts. 0012. . Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. They are the future as also mentioned regularly by Eric Topol. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). 1029/9/2000 SPL $0. Search for Betafem BV, Fleurstat or Viraleze and you will often get competing products but no reference to what you searched for (that is the way Google works). caBC OnLine Partnership Office E161, 4000 Seymour Place PO Box 9412, Stn Prov Govt Victoria, BC V8W 9V1Share. The news flow coming from SPL of latehas been lackluster at best. “If humans respond in a similar way, the benefits of treatment. IMO maybe you positive posters should just take a breather for a little while and wait until the tide turns and this company shows some signs of life?Sept 28 (Reuters) - Starpharma Holdings Ltd (SPL) : REQUESTS FOR A TRADING HALT PENDING AN ANNOUNCEMENT TO MARKET REGARDING A PROPOSED EQUITY CAPITAL. 0. , page-3. SPL Price at posting: 16. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Join the HotCopper ASX share market forum today for free. SPL Ann: Application for quotation of securities - SPL SPL starpharma holdings limited Ann: Application for quotation of securities - SPL ASX News 851. 70% 14. Advertise on HotCopper. 43M. Over the 3 year period the index has remained at around 40,000 whereas the SPL SP has dropped around 70%. In summary, there appears to be a massive financial incentive ($7m per year) for SPL to keep turnover below $20m, until such time as sufficient progress has been made on all fronts for profitability to become a. ASX - By Stock. 5¢. The 407730 is a sound level meter that measures from 40 to 130dB with an accuracy of 2dB. SPL has great optionality, potential and a healthy balance sheet to ride out the current storm. I know that Company's have to concentrate on the task at hand but an awareness of the World Economy is important. The lab that is. DYOR Why am am I still positive well let's go through my path to here in 2016/17/18 I was buying shares I bought one package of 100,000 for 66 cents and ended. Firstly, I’m a big fan of SPL and proud of all of their achievements to date (even picked up a few more shares the other day). Market Cap $77. $0. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . 0¢. . Although with SPL's track record an exceptionally good news announcement seems unlikely, it is within the realms of possibility - and this seems to be what makes SPL worth a gamble. ASX - By Stock. 11%. 5¢. Each to their own. Market . Share Financial Analysis: "Dr Jackie Fairley, CEO, Starpharma, commented:These very positive results for DEP® cabazitaxel in three common and hard-to-treat cancers demonstrate its therapeutic and commercial value" The phase 2 results look great and certainly demonstrate therapeutic value. . Created with Sketch. . IMO the Starpharma HQ kool-aide would be tasting pretty bitter these days. 5. Forums. Today it closes up 5% on the high of the bar and all we here. Enquire Now & Supercharge Your Brand with HotCopper 17 Oct 2023. I visited their offices in Melbourne near the Alfred a few times and thought they were on to some pretty neat tech. Forums. 0¢. 0¢. Created with Sketch. (OTCQX: SPHRY | ASX: SPL) Thursday, June 25, 2020 12:00 p. it certainly is a confidence booster to keep on topping upGood luck with whatever investments you may hold at the moment, and if you’re still in SPL, hopefully it will get a bit of a bounce soon. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. 11%. Merck will fund the research, although Starpharma doesn’t expect the fees to be material, and. Latest Posts | Join the HotCopper forum today for free, page-1. Time flies. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Even Pfizer won’t comment on him. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. 72. Market . Yes I am sure @sarge17 some will come on here today that have been predicting a $2 share price for more than 6 months because it has finally hit that target today saying “I toldNotification of cessation of securities - SPL. I think this is the start of a trail that may lead somewhere in hopefully SPL offering shareholder clearer explainations and referenced articles / posters etc in announcements being on website and then later being unavaliable is a process across the ASX that has to be stopped. 1541401. Everyone holding SPL shares should now realise that unless they can have a deal signed on at least one of the Dep candidates within 3 to 6 months with a substantial upfront payment then a CR will definately be on the cards. (OTCQX: SPHRY | ASX: SPL) Thursday, June 25, 2020 12:00 p. 3¢. Join the HotCopper ASX share market forum today for free. ASX - By Stock. ASX - General. 0. Created with Sketch. Become the CEO of Starpharma Step 2. Latest Posts. ASX - General. 16,161,259. 8. 82%)And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Latest Posts. Join the HotCopper ASX share market forum today for free. Last updated 15. 8¢. Target our investor community with our suite of Hotcopper Advertising opportunities. ASX - Short Term Trading. 59pm 17/11/2023 ? HotCopper has news, discussion, prices and market data on SYRAH RESOURCES LIMITED. I constantly question why I continue to subject myself to the ongoing. It was fairly obvious to the market that a crap raise was coming, and the SP might rise on this last chance in a while being out of the way before SPL is well capitalised. So much coming up with Viraleze and DEP Starpharma team will be working very hard at the moment with so many balls in the air. . . In part it oversees accelerated research initiatives to develop responses to unmet needs. All along, SPL have said that they may sell off this entire arm of the business, or in fact once the Dep oncology advances further, perhsps split SPL into different businesses on the asx or to be sold off as completely separate businesses. 03% or subsequently a decrease in shorts of. Last updated 15. 0¢. Share It's confusing isn't it So what we have in pre-clinical trials Dep Docetaxel has been used in combination with Gemcitabine Dep Cabazitaxel has been used in combination with GemcitabineReading the TGA decision to fine Starpharma re Viraleze in 2021, and the requirement that SPL apply for approval of Viraleze as Medicine not Medical Device which has been the approval category in many other jurisdictions, I understand from questions I asked at the November 2022 AGM that SPL paid the fine and were concerned that there. SPL need to show and reassure them that AZD0466 was cancelled not because of the dendrimer technology. it's a mess with multiple Substantial Holders dumping like this all while HQ remain. Share Many media conferences during the Pandemic we heard of Victorian initiatives for covid treatments or preventative by Dan Andrews or Brett Sutton - so VICTORIA has questions to answer. Share It is VERY disappointing that a CEO, Chair and company secretary can still throw a Sky and Land logo onto a corporate presentation as an indication of a partnership even though after 6. but have sent email to other companies CEO etc too, with some response, but all are dead end reply or will address and get in contact soon. Market . 0000. If they have poster data now it shoud be released to shareholders especially since they have used qualifying words such as good etc etc .